We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Conversion From Fast Acting Oral Opioids to Abstral®

This study has been terminated.
(Recruitment difficulties)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01315886
First Posted: March 15, 2011
Last Update Posted: April 5, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Orexo AB
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 7, 2011
  Primary Completion Date: December 7, 2011 (Final data collection date for primary outcome measure)

To Top